InsiderClue
Insiders · Profile

Hanley Jr. Michael Conick

Chief Commercial Officer at Spyre Therapeutics. Filing since 8 Jun 2022. CIK 0001791413

Company
Date
Role
Action
Shares
Amount
Of holding
SYRE Spyre Therapeutics, Inc.
8 Jun 2022
Chief Commercial Officer
Bought
28,200
$20.02K
353%
1 decision on file.